๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

SP 132 IDH1/IDH2 mutations predict survival in glioma and AML

โœ Scribed by M. Hegi


Book ID
117661719
Publisher
Elsevier Science
Year
2011
Tongue
English
Weight
52 KB
Volume
47
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


IDH1 and IDH2 mutations in gliomas
โœ Cohen, Adam L. (author);Holmen, Sheri L. (author);Colman, Howard (author) ๐Ÿ“‚ Article ๐Ÿ“… 2013 ๐Ÿ› Current Medicine Group LLC 1 ๐ŸŒ English โš– 193 KB
Metabolism of glioma and IDH1/IDH2 mutat
โœ Rossetto, M.; Ciccarino, P.; Boisselier, B.; Labussiere, M.; Sanson, M. ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› Masson Editeur ๐ŸŒ English โš– 178 KB
IDH1andIDH2Mutations in Gliomas
โœ Cohen, Adam L.; Holmen, Sheri L.; Colman, Howard ๐Ÿ“‚ Article ๐Ÿ“… 2013 ๐Ÿ› Springer ๐ŸŒ English โš– 193 KB
IDH1 and IDH2 hotspot mutations are not
โœ Zachary J. Reitman; Natasha J. Olby; Christopher L. Mariani; Rachael Thomas; Mat ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 101 KB

With great interest, we read the recent publication ''CD44positive cells are responsible for gemcitabine resistance in pancreatic cancer cells'' by Hong et al. 1 In this study, the authors established gemcitabine-resistant pancreatic cancer cells in vitro and characterized them in various ways, in v